tanshinone has been researched along with Parkinson Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Gaire, BP; Subedi, L | 1 |
| Gong, H; Huang, K; Ji, K; Liu, Y; Wang, Z; Yang, X; Yu, T; Zhao, Y | 1 |
| Jing, X; Lou, H; Ren, M; Wang, L; Wei, X; Zhang, X | 1 |
1 review(s) available for tanshinone and Parkinson Disease
| Article | Year |
|---|---|
Tanshinone IIA: A phytochemical as a promising drug candidate for neurodegenerative diseases.
Topics: Abietanes; Alzheimer Disease; Animals; Brain Ischemia; Humans; Multiple Sclerosis; Neurodegenerative Diseases; Neuroprotective Agents; Parkinson Disease | 2021 |
2 other study(ies) available for tanshinone and Parkinson Disease
| Article | Year |
|---|---|
Inhibition effects of tanshinone on the aggregation of α-synuclein.
Topics: Abietanes; alpha-Synuclein; Animals; Animals, Genetically Modified; Caenorhabditis elegans; Curcumin; Escherichia coli; Humans; Molecular Structure; Parkinson Disease; Protein Folding | 2016 |
Neuroprotective Effects of Tanshinone I Against 6-OHDA-Induced Oxidative Stress in Cellular and Mouse Model of Parkinson's Disease Through Upregulating Nrf2.
Topics: Abietanes; Animals; Antioxidant Response Elements; Cell Death; Cell Line, Tumor; Corpus Striatum; Humans; Male; Mice, Inbred C57BL; Motor Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Oxidopamine; Parkinson Disease; Transcription, Genetic; Up-Regulation | 2016 |